The rise and fall, and rise of Oc Ugen
RedditOn April 12, the FDA put a hold on Ocugen’s phase 2/3 immuno-bridging study of Covaxin, designed to show that it could protect people in the U.S. as effectively as shown in trials in India. The action came 10 days after the World Health Organization su…